p107 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of p107 Antibodies for investigating the role of p107 protein in cell cycle regulation and tumor suppression. p107 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The p107 protein, a member of the retinoblastoma (Rb) family, plays a crucial role in regulating the cell cycle by controlling the transition from the G1 phase to the S phase. p107 maintains proper cellular proliferation and differentiation, making it an essential focus in cancer research. Dysregulation of p107 has been linked to various malignancies, highlighting its importance in understanding tumorigenesis. Research has shown that p107 interacts with E2F transcription factors to regulate gene expression during cell cycle progression. Understanding p107's molecular mechanisms and interactions provides valuable insights into cell cycle control and cancer development. p107 expression patterns vary across different tissue types and developmental stages, offering opportunities for tissue-specific research. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of cell cycle regulation and cancer biology, contributing to the development of new therapeutic approaches.